Amgen (AMGN) earnings

Earnings (net income) · fiscal 2025
$7.71B

Amgen (AMGN) reported net income of $7.71B in fiscal 2025 (the year ended December 31, 2025). That is 88.5% higher than the $4.09B of fiscal 2024. Figures as of 18 Nov 2026, 05:58 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$7.71B
Change on fiscal 2024
+88.5%
Growth, 5 years
+1.2% a year
Growth, 10 years
+1.1% a year
Highest on record
$8.39Bfiscal 2018
Lowest on record
$1.98Bfiscal 2017
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Amgen earnings, in more detail

Over the five fiscal years to 2025 net income grew at a compound 1.2% a year; over ten years the rate was 1.1% a year. Across the 19 fiscal years on record (2007–2025), the highest was $8.39B in fiscal 2018 and the lowest $1.98B in fiscal 2017.

History · 19 fiscal years

Earnings (net income) by fiscal year

Amgen earnings, year by year

Amgen (AMGN) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$7.71B 88.5% up
2024$4.09B 39.1% down
2023$6.72B 2.5% up
2022$6.55B 11.2% up
2021$5.89B 18.9% down
2020$7.26B 7.4% down
2019$7.84B 6.6% down
2018$8.39B 324.2% up
2017$1.98B 74.4% down
2016$7.72B 11.3% up
2015$6.94B 34.5% up
2014$5.16B 1.5% up
2013$5.08B 16.9% up
2012$4.35B 18.0% up
2011$3.68B 20.4% down
2010$4.63B 0.5% up
2009$4.61B 13.6% up
2008$4.05B 31.6% up
2007$3.08B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Amgen and comparable companies
CompanyEarnings (net income)Fiscal year
Novartis NVS$13.98B2025
AstraZeneca AZN$10.23B2025
Thermo Fisher Scientific TMO$6.70B2025
Amgen AMGN$7.71B2025
Gilead Sciences GILD$8.51B2025
Abbott Laboratories ABT$6.52B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on AMGN

Amgen, figure by figure

Amgen (AMGN) overview: price, valuation and scorecardAll health care companies by market value

Amgen earnings: questions and answers

What is Amgen's net income?

Amgen (AMGN) reported net income of $7.71B in fiscal 2025 (the year ended December 31, 2025). That is 88.5% higher than the $4.09B of fiscal 2024.

What is the growth rate of Amgen's net income?

Over the five fiscal years to 2025 net income grew at a compound 1.2% a year; over ten years the rate was 1.1% a year.

What are the highest and lowest net income figures on record for Amgen?

Across the 19 fiscal years on record (2007–2025), the highest was $8.39B in fiscal 2018 and the lowest $1.98B in fiscal 2017.

How is Amgen's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Amgen (AMGN) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/AMGN/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.